Aminated β-1,3-D-glucan has a dose-dependent effect on wound healing in diabetic db/db mice

Wound Repair and Regeneration

Volumn 19, Issue 5, 2011, Pages 579-587

  Berdal, Margrete ^a   Appelbom, Hege I ^a   Eikrem, Jorunn H ^a   Lund, Åse ^a   Busund, Lill Tove ^a,b   Hanes, Robert ^a   Seljelid, Rolf ^a   Jenssen, Trond ^a,c  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINATED BETA 1,3 GLUCAN; BETA 1,3 GLUCAN; INSULIN; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; RECOMBINANT SOMATOMEDIN C; SODIUM CHLORIDE; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MOUSE; NONHUMAN; OPEN STUDY; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT DURATION; WOUND CLOSURE; WOUND HEALING;

AMINATION; ANIMALS; BETA-GLUCANS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GRANULATION TISSUE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED C57BL; PLATELET-DERIVED GROWTH FACTOR; SKIN; WOUND HEALING;

EID: 80052717028     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2011.00715.x     Document Type: Article

References (40)

1. Myrup B, deMaat M, Rossing P, Gram J, Kluft C, Jespersen J,. Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. Thromb Res 1996; 81: 485-90. (Pubitemid 26100415)
2. Parkhouse N, Lequesne PM,. Impaired neurogenic vascular-response in patients with diabetes and neuropathic foot lesions. N Engl J Med 1988; 318: 1306-9.
3. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM,. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study. Kidney Int 2000; 58: 1703-10.
4. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R,. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990; 136: 1235-46. (Pubitemid 20210322)
5. Hill HR, Augustine NH, Rallison ML, Santos JI,. Defective monocyte chemotactic responses in diabetes mellitus. J Clin Immunol 1983; 3: 70-7. (Pubitemid 13154041)
6. Luger A, Schernthaner G, Urbanski A, Luger TA,. Cytokine production in patients with newly diagnosed insulin-dependent (type I) diabetes mellitus. Eur J Clin Invest 1988; 18: 233-6.
7. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H,. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990; 87: 9010-4. (Pubitemid 120007639)
8. Zykova SN, Svartberg J, Seljelid R, Iversen H, Lund A, Svistounov DN, Jenssen TG,. Release of TNF-alpha from in vitro-stimulated monocytes is negatively associated with serum levels of apolipoprotein B in patients with type 2 diabetes. Scand J Immunol 2004; 60: 535-42. (Pubitemid 39487523)
9. Chu X, Newman J, Park B, Nares S, Ordonez G, Iacopino AM,. In vitro alteration of macrophage phenotype and function by serum lipids. Cell Tissue Res 1999; 296: 331-7. (Pubitemid 29219184)
10. Goren I, Muller E, Schiefelbein D, Christen U, Pfeilschifter J, Muhl H, Frank S,. Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol 2007; 127: 2259-67. (Pubitemid 47258485)
11. Brown DL, Kane CD, Chernausek SD, Greenhalgh DG,. Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic and nondiabetic mice. Am J Pathol 1997; 151: 715-24. (Pubitemid 27385603)
12. Doxey DL, Ng MC, Dill RE, Iacopino AM,. Platelet-derived growth factor levels in wounds of diabetic rats. Life Sci 1995; 57: 1111-23.
13. Blakytny R, Jude EB, Martin GJ, Boulton AJ, Ferguson MW,. Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol 2000; 190: 589-94. (Pubitemid 30164489)
14. Kiritsy CP, Antoniades HN, Carlson MR, Beaulieu MT, D'Andrea M, Lynch SE,. Combination of platelet-derived growth factor-BB and insulin-like growth factor-I is more effective than platelet-derived growth factor-BB alone in stimulating complete healing of full-thickness wounds in "older" diabetic mice. Wound Rep Regen 1995; 3: 340-50.
15. Wieman TJ, Smiell JM, Su Y,. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 1998; 21: 822-7. (Pubitemid 28487079)
16. Zykova SN, Jenssen TG, Berdal M, Olsen R, Myklebust R, Seljelid R,. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 2000; 49: 1451-8.
17. Kokoshis PL, Williams DL, Cook JA, Diluzio NR,. Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan. Science 1978; 199: 1340-2.
18. Almdahl SM, Bogwald J, Hoffman J, Giercksky KE, Seljelid R,. Protection by aminated glucan in experimental endogenous peritonitis. Eur Surg Res 1987; 19: 78-85. (Pubitemid 17008050)
19. Browder W, Williams D, Pretus H, Olivero G, Enrichens F, Mao P, Franchello A,. Beneficial effect of enhanced macrophage function in the trauma patient. Ann Surg 1990; 211: 605-12.
20. Rasmussen LT, Seljelid R,. Novel immunomodulators with pronounced in vivo effects caused by stimulation of cytokine release. J Cell Biochem 1991; 46: 60-8.
21. Seljelid R, Figenschau Y, Bogwald J, Rasmussen LT, Austgulen R,. Evidence that tumor necrosis induced by aminated beta 1-3D polyglucose is mediated by a concerted action of local and systemic cytokines. Scand J Immunol 1989; 30: 687-94. (Pubitemid 20015841)
22. Suzuki T, Ohno N, Chiba N, Miura NN, Adachi Y, Yadomae T,. Immunopharmacological activity of the purified insoluble glucan, zymocel, in mice. J Pharm Pharmacol 1996; 48: 1243-8. (Pubitemid 27035912)
23. Berdal M, Appelbom HI, Eikrem JH, Lund A, Zykova S, Busund LT, Seljelid R, Jenssen T,. Aminated beta-1,3-d-glucan improves wound healing in diabetic db/db mice. Wound Rep Regen 2007; 15: 825-32. (Pubitemid 350135230)
24. Coleman DL,. Diabetes-obesity syndromes in mice. Diabetes 1982; 31 (Suppl 1 Pt 2): 1-6. (Pubitemid 12128678)
25. Molina JM, Premdas FH, Klenck RE, Eddlestone G, Oldham SB, Lipson LG,. The dynamic insulin secretory response of isolated pancreatic islets of the diabetic mouse. Evidence for a gene dosage effect on insulin secretion. Diabetes 1984; 33: 1120-3. (Pubitemid 15204592)
26. Wang PY,. Palmitic acid as an excipient in implants for sustained release of insulin. Biomaterials 1991; 12: 57-62.
27. Rubini M, Werner H, Gandini E, Roberts CT Jr, LeRoith D, Baserga R,. Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor-1 (IGF-1) receptor gene. Exp Cell Res 1994; 211: 374-9. (Pubitemid 24174971)
28. Bogwald J, Seljelid R,. Coupling of polysaccharides activated by means of chloroacetaldehyde dimethyl acetal to amines or proteins by reductive amination. Carbohydr Res 1986; 148: 101-7.
29. Abramov Y, Golden B, Sullivan M, Botros SM, Miller JJ, Alshahrour A, Goldberg RP, Sand PK,. Histologic characterization of vaginal vs. abdominal surgical wound healing in a rabbit model. Wound Rep Regen 2007; 15: 80-6. (Pubitemid 46146666)
30. Littell RC, Pendergast J, Natarajan R,. Modelling covariance structure in the analysis of repeated measures data. Stat Med 2000; 19: 1793-819. (Pubitemid 30436064)
31. Greenhalgh DG, Hummel RP III, Albertson S, Breeden MP,. Synergistic actions of platelet-derived growth factor and the insulin-like growth factors in vivo. Enhancement of tissue repair in genetically diabetic mice. Wound Rep Regen 1993; 1: 69-81.
32. Konopski Z, Smedsrod B, Seljelid R, Eskeland T,. A novel immunomodulator soluble aminated beta-1,3-D-glucan: binding characteristics to mouse peritoneal macrophages. Biochim Biophys Acta 1994; 1221: 61-5.
33. Brown GD, Gordon S,. Immune recognition-a new receptor for beta-glucans. Nature 2001; 413: 36-7. (Pubitemid 32843478)
34. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D'Amore PA,. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 2007; 170: 1178-91. (Pubitemid 47339326)
35. Wei D, Zhang L, Williams DL, Browder IW,. Glucan stimulates human dermal fibroblast collagen biosynthesis through a nuclear factor-1 dependent mechanism. Wound Rep Regen 2002; 10: 161-8. (Pubitemid 34760894)
36. Browder W, Williams D, Lucore P, Pretus H, Jones E, McNamee R,. Effect of enhanced macrophage function on early wound healing. Surgery 1988; 104: 224-30.
37. Witte MB, Kiyama T, Barbul A,. Nitric oxide enhances experimental wound healing in diabetes. Br J Surg 2002; 89: 1594-601. (Pubitemid 35404331)
38. Altavilla D, Saitta A, Cucinotta D, Galeano M, Deodato B, Colonna M, Torre V, Russo G, Sardella A, Urna G, Campo GM, Cavallari V, Squadrito G, Squadrito F,. Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes 2001; 50: 667-74. (Pubitemid 32195234)
39. Sener G, Sert G, Ozer SA, Arbak S, Uslu B, Gedik N, Yanoglu-Dulger G,. Pressure ulcer-induced oxidative organ injury is ameliorated by beta-glucan treatment in rats. Int Immunopharmacol 2006; 6: 724-32.
40. Leibovich SJ, Danon D,. Promotion of wound repair in mice by application of glucan. J Reticuloendothel Soc 1980; 27: 1-11. (Pubitemid 10210635)